Briefing Information for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee
Johnson & Johnson Pharmaceutical Research & Development, L.L.C
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Briefing Material [PDF]